Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study of metastasis

09.07.2004


Metastasis of cancer may cause as many, if not more, deaths than cancer itself. Amongst other reasons, this is because it is very difficult to know where the new tumour is going to develop. Moreover, the mechanisms of metastasis are still not well understood, although a lot of research into it is taking place and advances are being made. Dominion Pharmakine is a company located at the Bizkaia Technological Park where they are studying metastasis.




At times, a cell in our body may suffer a mutation and starts to multiply in an uncontrolled manner. All the cells thus formed result in a tumour which interferes in the form and functions of the tissue of which it is part. Moreover, the tumour provokes the creation of new blood vessels, which assures a good food supply.

If the tumour limits itself to growing, it is said to be a benign tumour and, in most cases, does not require treatment. But, if malignant, it must be treated. If not extirpated, pharmaceutical drugs have to be used to combat the tumour. But the tumour usually has a number of defence mechanisms. One of these is a proteic layer difficult to penetrate by some of these drugs. Dominion Pharmakine is studying which these area and also the suitability of the molecular targets used by the new drugs for bonding to the pathological cells, i.e. they are trying to identify the molecule that best offers the possibility of penetration of the unhealthy cell.


But unfortunately, malign tumours, apart from growing, may spread throughout the body, i.e. they may produce a metastasis. Some of the cells separate from the tumour and are carried to other parts of the body through the blood system, via the newly-formed vessels. Once in the blood system, it is distributed through the whole body until they attach themselves to some new tissue and initiate a new tumour.

Metastasis initiates as a consequence of two changes in the genetic expression and protein synthesis that occur in the initial tumour. Dominion Pharmakine is also investigating the relationship between this genetic expression and metastasis. From this information, two objectives are sought: on the one hand, predicting the evolution of the tumour using the genetic expression arising and, on the other, designing new specific drugs based on this expression.

The Dominion Pharmakine company was formed as a spin off of the Faculty of Medicine at the University of the Basque Country.

Eneko Imaz | Basque Research
Further information:
http://www.pharmakine.com
http://www.elhuyar.com

More articles from Life Sciences:

nachricht New risk factors for anxiety disorders
24.02.2017 | Julius-Maximilians-Universität Würzburg

nachricht Stingless bees have their nests protected by soldiers
24.02.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>